Finance
Mounjaro is the brand name for tirzepatide, a prescription injectable medication developed by Eli Lilly and Company. It was first approved by the U.S. Food and Drug Administrati...
Open articleTag Archive
Explore 5 published pages tagged with Mounjaro, grouped automatically from article text, entity focus, and recurring topical signals.
Tagged Articles
Finance
Mounjaro is the brand name for tirzepatide, a prescription injectable medication developed by Eli Lilly and Company. It was first approved by the U.S. Food and Drug Administrati...
Open articleFinance
Mounjaro (tirzepatide) is a once-weekly injectable prescription medication approved by the U.S. Food and Drug Administration for type 2 diabetes and chronic weight management. T...
Open articleFinance
Mounjaro, manufactured by Eli Lilly, is a GLP-1 receptor agonist approved for weight management and type 2 diabetes. The list price for a 2.5 mg/0.5 mL single-dose pen is approx...
Open articleFinance
Mounjaro contains tirzepatide as its sole active pharmaceutical ingredient. Tirzepatide is a synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide a...
Open articleFinance
Mounjaro (tirzepatide) received initial FDA approval in 2022 for type 2 diabetes under the brand name Mounjaro. The same drug is now approved for chronic weight management in ad...
Open article